Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Intervalo de año de publicación
1.
Oxid Med Cell Longev ; 2021: 3683796, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34621463

RESUMEN

Aerobic training (AT) promotes several health benefits that may attenuate the progression of obesity associated diabetes. Since AT is an important nitric oxide (NO-) inducer mediating kidney-healthy phenotype, the present study is aimed at investigating the effects of AT on metabolic parameters, morphological, redox balance, inflammatory profile, and vasoactive peptides in the kidney of obese-diabetic Zucker rats receiving L-NAME (N(omega)-nitro-L-arginine methyl ester). Forty male Zucker rats (6 wk old) were assigned into four groups (n = 10, each): sedentary lean rats (CTL-Lean), sedentary obese rats (CTL-Obese), AT trained obese rats without blocking nitric oxide synthase (NOS) (Obese+AT), and obese-trained with NOS block (Obese+AT+L-NAME). AT groups ran 60 min in the maximal lactate steady state (MLSS), five days/wk/8 wk. Obese+AT rats improved glycemic homeostasis, SBP, aerobic capacity, renal mitochondria integrity, redox balance, inflammatory profile (e.g., TNF-α, CRP, IL-10, IL-4, and IL-17a), and molecules related to renal NO- metabolism (klotho/FGF23 axis, vasoactive peptides, renal histology, and reduced proteinuria). However, none of these positive outcomes were observed in CTL-Obese and Obese+AT+L-NAME (p < 0.0001) groups. Although Obese+AT+L-NAME lowered BP (compared with CTL-Obese; p < 0.0001), renal damage was observed after AT intervention. Furthermore, AT training under conditions of low NO- concentration increased signaling pathways associated with ACE-2/ANG1-7/MASr. We conclude that AT represents an important nonpharmacological intervention to improve kidney function in obese Zucker rats. However, these renal and metabolic benefits promoted by AT are dependent on NO- bioavailability and its underlying regulatory mechanisms.


Asunto(s)
Riñón/metabolismo , Óxido Nítrico/metabolismo , Obesidad/metabolismo , Condicionamiento Físico Animal , Transducción de Señal/efectos de los fármacos , Animales , Disponibilidad Biológica , Glucemia/metabolismo , Inhibidores Enzimáticos/farmacología , Masculino , Mitocondrias/metabolismo , Modelos Animales , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Oxidación-Reducción/efectos de los fármacos , Ratas , Ratas Zucker , Especies Reactivas de Oxígeno/metabolismo
2.
Rev. bras. ciênc. mov ; 29(1): [1-12], jan.-mar. 2021. tab, ilus
Artículo en Portugués | LILACS | ID: biblio-1348081

RESUMEN

O presente estudo analisou a relação entre cronotipo, níveis de ansiedade, depressão e estresse, bem como níveis de condicionamento cardiorrespiratório em jovens. Métodos: Foi analisado um total de 36 participantes com idades entre 18 e 28 a nos, saudáveis e que atendessem ao cronotipo matutino e vespertino. Análises de nível de atividade física, consumo máximo de oxigênio, níveis de depressão, ansiedade e estresse foram realizadas com testes específicos. Em todos os cálculos foram utilizados um alfa de p<0.05 para análise estatística. Resultados: O nível de atividade física mostrou que a porcentagem dos matutinos suficientemente ativos foi de 58% comparado com 23.5% dos vespertinos. Mulheres com cronotipo vespertino apresentaram níveis menores de VO2máx quando comparados com as mulheres com cronotipo matutino (p=0.04). Os participantes vespertinos apresentaram níveis maiores de ansiedade (p=0.02) comparados com os matutinos e esses dados foram evidentes nos participantes do sexo feminino onde as mulheres do cronotipo vespertino apresentaram níveis maiores de ansiedade (p=0.03) comparados com mulheres de cronotipo matutino. Conclusão: Portanto, o estudo conclui que indivíduos do cronotipo vespertino apresentaram menores níveis de atividade física e maiores níveis de ansiedade evidenciados principalmente nas mulheres.(AU)


The present study analyzed a relationship between schedule, anxiety, depression and stress levels, as well as cardiorespiratory fitness levels in young people. Methods: A total of 36 healthy participants aged 18 to 28 years who met the criteria for chronotypes morning type and evening type were analyzed. Analyzes of physical activity level, maximal oxygen uptake, depression, anxiety and stress levels were performed. In all calculations, an alpha of p <0.05 was used for statistical analysis. Results: The level of physical activity was higher in morning types 58% compared to 23.5% of evening types. Women with evening chronotype had lower VO2max levels compared with women with a morning chronotype (p= 0.04). Evening types had higher anxiety levels (p= 0.02) compared to morning types and these data were evidenced in female participants with higher anxiety levels (p=0.03) compared to women with a morning chronotype. Conclusion: Therefore, the study concludes that young people with a evening chronotype exhibited lower levels of physical activity and higher anxiety levels, especially in women.(AU)


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Adulto Joven , Ansiedad , Consumo de Oxígeno , Ejercicio Físico , Trastornos del Sueño del Ritmo Circadiano , Depresión , Capacidad Cardiovascular , Trastornos de Ansiedad , Estrés Psicológico , Relojes Biológicos , Frecuencia Cardíaca
3.
Sci Rep ; 10(1): 11708, 2020 07 16.
Artículo en Inglés | MEDLINE | ID: mdl-32678132

RESUMEN

Patients in maintenance hemodialisys (HD) present sleep disorders, increased inflammation, unbalanced redox profiles, and elevated biomarkers representing endothelial dysfunction. Resistance training (RT) has shown to mitigate the loss of muscle mass, strength, improve inflammatory profiles, and endothelial function while decreasing oxidative stress for those in HD. However, the relation between those factors and sleep quality are inadequately described. The aim of this study was to verify the effects of 3 months of RT on sleep quality, redox balance, nitric oxide (NO) bioavailability, inflammation profile, and asymmetric dimethylarginine (ADMA) in patients undergoing HD. Our primary goal was to describe the role of RT on sleep quality. Our secondary goal was to evaluate the effect of RT on NO, metabolism markers, and inflammatory and redox profiles as potential mechanisms to explain RT-induced sleep quality changes. Fifty-five men undergoing maintenance hemodialysis were randomized into either a control (CTL, n = 25) and RT group (RTG; n = 30). Participants in the RT group demonstrated an improvement in sleep pattern, redox, inflammatory profiles, and biomarkers of endothelial function (NO2- and ADMA). This group also increased muscle strength (total workload in RT exercises of upper and lower limbs). These findings support that RT may improve the clinical status of HD patients by improving their sleep quality, oxidative and inflammatory parameters.


Asunto(s)
Oxidación-Reducción , Diálisis Renal , Insuficiencia Renal Crónica/terapia , Entrenamiento de Fuerza/métodos , Trastornos del Sueño-Vigilia/terapia , Sueño , Anciano , Arginina/análogos & derivados , Arginina/análisis , Arginina/metabolismo , Biomarcadores/análisis , Biomarcadores/metabolismo , Endotelio/metabolismo , Humanos , Inflamación/metabolismo , Masculino , Persona de Mediana Edad , Fuerza Muscular , Óxido Nítrico/análisis , Óxido Nítrico/metabolismo , Estrés Oxidativo , Resultado del Tratamiento
4.
World J Gastroenterol ; 21(22): 6990-8, 2015 Jun 14.
Artículo en Inglés | MEDLINE | ID: mdl-26078577

RESUMEN

AIM: To investigate the effects of bariatric surgery on metabolic parameters, incretin hormone secretion, and duodenal and ileal mucosal gene expression. METHODS: Nine patients with type 2 diabetes mellitus (T2DM), chronic serum hyperglycemia for more than 2 years, and a body mass index (BMI) of 30-35 kg/m(2) underwent metabolic surgery sleeve gastrectomy with transit bipartition between May 2011 and December 2011. Blood samples were collected pre and 3, 6 and 12 mo postsurgery. Duodenal and ileal mucosa samples were collected pre- and 3 mo postsurgery. Pre- and postoperative blood samples were collected in the fasting state before ingestion of a standard meal (520 kcal) and again 30, 60, 90, and 120 min after the meal to determine hemoglobin A1c (HbA1c) levels and the lipid profile, which consisted of triglyceride and total cholesterol levels. Intestinal gene expression of p53 and transforming growth factor (TGF)-ß was analyzed using quantitative reverse-transcription PCR. Gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) were quantified using the enzyme-linked immunoassay method and analyzed pre- and postoperatively. Student's t test or repeated measurements analysis of variance with Bonferroni corrections were performed as appropriate. RESULTS: BMI values decreased by 15.7% within the initial 3 mo after surgery (31.29 ± 0.73 vs 26.398 ± 0.68, P < 0.05) and then stabilized at 22% at 6 mo postoperative, resulting in similar values 12 mo postoperatively (20-25 kg/m(2)). All of the patients experienced improved T2DM, with 7 patients (78%) achieving complete remission (HbA1c < 6.5%), and 2 patients (22%) achieving improved diabetes (HbA1c < 7.0% with or without the use of oral hypoglycemic agents). At 3 mo postoperatively, fasting plasma glucose had also decreased (59%) (269.55 ± 18.24 mg/dL vs 100.77 ± 3.13 mg/dL, P < 0.05) with no further significant changes at 6 or 12 mo postoperatively. In the first month postoperatively, there was a complete withdrawal of hypoglycemic medications in all patients, who were taking at least 2 hypoglycemic drugs preoperatively. GLP-1 levels significantly increased after surgery (149.96 ± 31.25 vs 220.23 ± 27.55) (P < 0.05), while GIP levels decreased but not significantly. p53 gene expression significantly increased in the duodenal mucosa (P < 0.05, 2.06 fold) whereas the tumor growth factor-ß gene expression significantly increased (P < 0.05, 2.52 fold) in the ileal mucosa after surgery. CONCLUSION: Metabolic surgery ameliorated diabetes in all of the patients, accompanied by increased anti-proliferative intestinal gene expression in non-excluded segments of the intestine.


Asunto(s)
Cirugía Bariátrica , Diabetes Mellitus Tipo 2/etiología , Duodeno/metabolismo , Íleon/metabolismo , Mucosa Intestinal/metabolismo , Obesidad/cirugía , Adulto , Biomarcadores/sangre , Biopsia , Glucemia/metabolismo , Índice de Masa Corporal , Proliferación Celular , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/genética , Ayuno/sangre , Femenino , Gastrectomía , Polipéptido Inhibidor Gástrico/sangre , Regulación de la Expresión Génica , Péptido 1 Similar al Glucagón/sangre , Hemoglobina Glucada/metabolismo , Humanos , Hipoglucemiantes/uso terapéutico , Mucosa Intestinal/patología , Masculino , Persona de Mediana Edad , Obesidad/sangre , Obesidad/complicaciones , Obesidad/diagnóstico , Obesidad/genética , Periodo Posprandial , Inducción de Remisión , Factores de Tiempo , Factor de Crecimiento Transformador beta/genética , Factor de Crecimiento Transformador beta/metabolismo , Resultado del Tratamiento , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismo , Pérdida de Peso
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA